Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
Treatment response depends on deficiency severity, route of administration, underlying cause, patient age, concurrent medical conditions, and medication interactions
Evidence type: Human RCT | Observational | Animal | In vitro | Regulatory Mechanism of Action AOD-9604 mimics the fat-metabolizing region of growth hormone
It creates a thin, flexible film on the surface of your skin
Supporting your patients: Reconstitution essentials for EGRIFTA WR TM Patients will need: One 11.6 mg vial of EGRIFTA WR TM (Medication Box) One BD Plastipak TM 3 mL syringe with needle for mixingclear cap (Injection Box) One bottle of Bacteriostatic Water for Injection (Injection Box) Alcohol swabs (Injection Box) Draw Bacteriostatic Water Using the BD Plastipak TM 3 mL syringe (clear cap), draw 1.5 mL of Bacteriostatic Water for Injection from the bottle
Potency depends on the outcome youre measuring
